Compare Atomera Incorporated (ATOM) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Atomera Incorporated vs Recursion Pharmaceuticals Inc — how do they compare? Atomera Incorporated trades at $6.48 (market cap $241.98M), while Recursion Pharmaceuticals Inc trades at $3.37 (market cap $1.75B). The key difference: Recursion Pharmaceuticals Inc is far larger — about 7.2× Atomera Incorporated's market cap, and Atomera Incorporated is trading nearer its 52-week high, Recursion Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| ATOM | RXRX | |
|---|---|---|
Market Cap | $241.98M | $1.75B |
Sector | Technology | Health |
52-Week High | $12.11 | $6.79 |
52-Week Low | $1.99 | $2.84 |
Enterprise Value | $202.19M | $1.17B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Atomera Incorporated
Atomera is a semiconductor materials engineering company. Its Mears Silicon Technology (MST) is a patented thin film that enhances transistor performance, power efficiency, and cost for global chip manufacturers.
Read more on ATOM →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
